Rebecca Lara to Cognition Disorders
This is a "connection" page, showing publications Rebecca Lara has written about Cognition Disorders.
Connection Strength
0.052
-
Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial. J Child Adolesc Psychopharmacol. 2006 Oct; 16(5):525-40.
Score: 0.041
-
Characterization of potential outcome measures for future clinical trials in fragile X syndrome. J Autism Dev Disord. 2008 Oct; 38(9):1751-7.
Score: 0.011